CA Patent

CA2673856C — Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain

Assigned to Vertical Pharmaceuticals LLC · Expires 2018-11-27 · 7y expired

What this patent protects

Compositions, methods and systems for administration of small volume sufentanil-containing drug dosage forms to the oral mucosa of a subject are disclosed.

USPTO Abstract

Compositions, methods and systems for administration of small volume sufentanil-containing drug dosage forms to the oral mucosa of a subject are disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
CA2673856C
Jurisdiction
CA
Classification
—
Expires
2018-11-27
Drug substance claim
No
Drug product claim
No
Assignee
Vertical Pharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.